ClosedBusiness2020
2020 Targeted Translation Research Accelerator Grant Opportunity
Australian Government · Australia
The 2020 Targeted Translation Research Accelerator Grant Opportunity provides funding to an organisation to deliver a comprehensive accelerator package aimed at improving outcomes for diabetes and cardiovascular disease. It supports research translation, partnership projects, commercialisation and the establishment of research centres under the Medical Research Future Fund.
Funding
Up to $47M
Location
Australia
Who Can Apply
• Must have an Australian Business Number (ABN)
• Must be incorporated in Australia
• Must be one of the following: a medical research institute, a university, a corporate Commonwealth entity, a corporation (including businesses and not for profits), or a state or territory government entity
• Joint applications are encouraged if there is an eligible lead organisation
• Individuals are not eligible
• Partnerships are not eligible
• Unincorporated associations are not eligible
• Trusts are not eligible, except where an incorporated trustee applies on behalf of a trust
• Non-corporate Commonwealth entities are not eligible
• Organisations not included in section 3.1 of the grant opportunity guidelines are not eligible
To be eligible, applicants must have an Australian Business Number (ABN), be incorporated in Australia, and be one of the following entities in accordance with the Medical Research Future Fund Act 2015: a medical research institute, a university, a corporate Commonwealth entity, a corporation (including businesses and not for profits), or a state or territory government entity. Joint applications are encouraged if there is an eligible lead organisation. Individuals, partnerships, unincorporated associations, trusts (except where an incorporated trustee applies on behalf of a trust), non-corporate Commonwealth entities, and organisations not included in section 3.1 of the grant opportunity guidelines are not eligible.
What's Funded
Delivering the Accelerator as an independent organisation, establishing two research centres for diabetes and cardiovascular disease, supporting competitive research projects, funding partnership projects to progress drug and device development, nurturing early stage therapeutic research targets, and commissioning research to support health and commercial sector transformation.Before you apply
Check 2020 Targeted Translation Research Accelerator Grant Opportunity fit and evidence gaps
Use this business grant page to sanity-check eligibility, funding fit, evidence gaps and application effort before you commit days to drafting. If you already know the grant you want, the 48-hour audit gives a practical go/no-go view, reviewer-readiness score and next-step risks.
Get a 48-hour grant fit auditExpected Outcomes
Improved knowledge and translation into practice to reduce the burden of diabetes and cardiovascular disease, accelerated therapies for prevention, early detection and treatment, and progress toward commercialisation of novel therapeutics and devices.Grant not accepting applications
Applications for this round are closed. A new round may open in the future.
Browse open grantsKey Information
Applicant Types
companynon_profituniversitylocal_governmentother
Stage
established
Funding Purposes
researchcommercialisationinnovationcommunity
Keywords
Medical Research Future FundPreventive and Public Health Research Initiativediabetescardiovascular diseasemedical researchtranslation researchacceleratortherapeutics
Frequently Asked Questions
1
What is the 2020 Targeted Translation Research Accelerator Grant Opportunity?
The 2020 Targeted Translation Research Accelerator Grant Opportunity is a business grant offered by Australian Government in Australia, providing Up to $47M in funding. The 2020 Targeted Translation Research Accelerator Grant Opportunity provides funding to an organisation to deliver a comprehensive accelerator package aimed at improving outcomes for diabetes and cardiovascular disease. It supports research translation, partnership projects, commercialisation and the establishment of research centres under the Medical Research Future Fund.
2
How much funding does the 2020 Targeted Translation Research Accelerator Grant Opportunity provide?
The 2020 Targeted Translation Research Accelerator Grant Opportunity provides Up to $47M in funding.
3
Who is eligible for the 2020 Targeted Translation Research Accelerator Grant Opportunity?
- Must have an Australian Business Number (ABN)
- Must be incorporated in Australia
- Must be one of the following: a medical research institute, a university, a corporate Commonwealth entity, a corporation (including businesses and not for profits), or a state or territory government entity
- Joint applications are encouraged if there is an eligible lead organisation
- Individuals are not eligible
- Partnerships are not eligible
- Unincorporated associations are not eligible
- Trusts are not eligible, except where an incorporated trustee applies on behalf of a trust
- Non-corporate Commonwealth entities are not eligible
- Organisations not included in section 3.1 of the grant opportunity guidelines are not eligible
4
What activities are funded?
Delivering the Accelerator as an independent organisation, establishing two research centres for diabetes and cardiovascular disease, supporting competitive research projects, funding partnership projects to progress drug and device development, nurturing early stage therapeutic research targets, and commissioning research to support health and commercial sector transformation.
5
How do I apply for the 2020 Targeted Translation Research Accelerator Grant Opportunity?
Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.
Need help applying?
Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.